`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`CONOPCO, INC. dba UNILEVER
`
`Petitioner
`
`v.
`
`THE PROCTOR & GAMBLE COMPANY
`
`Patent Owner
`
`Case No. IPR2014-00507
`
`Patent 6,451,300
`
`REQUEST FOR REHEARING BY AN EXPANDED PANEL
`INCLUDING THE CHIEF ADMINISTRATIVE PATENT JUDGE
`UNDER 37 C.F.R. § 42.71(c)-(d)
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Table of Contents
`
`I.
`
`INTRODUCTION ........................................................................................... 1
`
`II. BACKGROUND ............................................................................................ 1
`
`III. LEGAL STANDARDS ................................................................................... 4
`
`A. The Standard Under 35 U.S.C. § 325(d)........................................................4
`
`B. The Standard of Review for Rehearing by an Expanded Panel ....................5
`
`IV. ARGUMENT .................................................................................................. 5
`
`A. The Decision Should Be Reheard by an Expanded Panel .............................5
`
`1. Inconsistent Analyses under 35 U.S.C. § 325(d) to Date ...........................6
`
`2. The Proper Scope of Analysis under § 325(d) ...........................................7
`
`B. The Decision Relies on Erroneous Factual Findings and a Misapprehension
`of Relevant Law ...................................................................................................8
`
`1. Improper Reliance on Estoppel Considerations .........................................9
`
`2. There Is No Statutory, Rule, or Policy Basis for Precluding a Petitioner
`from Filing a Second, Improved Petition ........................................................10
`
`3. The Board Committed Legal Error by Neglecting Substantial Differences
`in the Prior Art ................................................................................................11
`
`C. The 507 Petition Arguments are Not the Same or Substantially the Same .13
`
`V. CONCLUSION ............................................................................................. 15
`
`
`
`
`
`i
`
`
`
`
`
`Cases
`
`TABLE OF AUTHORITIES
`
`
`
`Page(s)
`
`Tafas v. Dudas
`541 F. Supp. 2d 805 (E.D. Va. 2008) ................................................................. 9
`
`In re Merck & Co., Inc.,
`800 F.2d 1091 (Fed. Cir. 1986) .................................................................... 7, 11
`
`Renda Marine, Inc. v. U.S.,
`509 F.3d 1372 (Fed. Cir. 2007) .......................................................................... 5
`
`Statutes
`
`35 U.S.C. § 314(a) ....................................................................................... 1, 10, 15
`
`35 U.S.C. § 315(e)(1) .............................................................................................. 9
`
`35 U.S.C. § 325(d) ......................................................................................... passim
`
`Other Authorities
`
`37 C.F.R. § 42.71(c) ...................................................................................... 1, 5, 17
`
`37 C.F.R. § 42.71(d) .......................................................................................... 1, 17
`
`
`
`ii
`
`
`
`Case IPR2014-00507
`
`
`I.
`
`INTRODUCTION
`Pursuant to 37 C.F.R. § 42.71(c)-(d), Petitioner Conopco, Inc. dba Unilever
`
`(“Unilever”) respectfully requests rehearing by an expanded panel—including the
`
`Chief Administrative Patent Judge—of the decision rejecting Unilever’s petition in
`
`this proceeding (“507 Petition”) under 35 U.S.C. § 325(d). Patent policy dictates
`
`rehearing by an expanded panel to address inconsistent panel interpretations of
`
`§ 325(d), including the proper scope and requirements for a panel’s analysis
`
`thereunder. See Board SOP (Revision 13) 2009, Section III(A)(2). Rehearing is
`
`also requested to address the mistakes of fact and law in the panel’s decision where
`
`the 507 Petition advanced numerous prior art references and arguments that were
`
`not the same or substantially the same as in Unilever’s previous petition. The
`
`Board abused its discretion in rejecting Unilever’s current petition, which
`
`specifically addressed the purported deficiencies of the first petition. The statutory
`
`framework and rules implementing inter partes reviews contemplate that a
`
`petitioner may file more than one petition during the statutory period, and § 325(d)
`
`should not amount to a de facto estoppel. Petitioner therefore seeks reconsideration
`
`of the 507 Petition on its merits under 35 U.S.C. § 314(a), and requests institution
`
`of trial on all proposed grounds of invalidity.
`
`II. BACKGROUND
`On August 14, 2013, Unilever filed a petition in IPR2013-00509 seeking
`
`1
`
`
`
`inter partes review of claims 1-25 of U.S. Patent No. 6,451,300 (“509 Petition”).
`
`Case IPR2014-00507
`
`
`On February 12, 2014, the Board entered a decision instituting trial as to claims 1-5,
`
`11-13, 16-20, 24, and 25 of the '300 patent, but not as to claims 6-10, 14, 15, and
`
`21-23 (“non-instituted claims”). IPR2013-00509, Paper 10 at 2, 12-16 (“509
`
`Decision”). As to certain non-instituted claims, the Board found that the
`
`information presented did not sufficiently show obviousness over a single reference
`
`(Kanebo) or a combination of references (Bowser and Evans), and failed to
`
`articulate “an adequate reason why a skilled artisan would have thought to
`
`incorporate the elements required by the claims.” Id. at 12, 15-16. Unilever sought
`
`rehearing (IPR2013-00509, Paper 12), but the Board reiterated that the 509 Petition
`
`did not contain sufficient support for the obviousness arguments advanced (id.,
`
`Paper 25 at 3-4).
`
`Unilever subsequently filed the 507 Petition as to all non-instituted claims,
`
`specifically “address[ing] the concerns expressed previously by the Board.” Id. at
`
`1-2. As the below chart illustrates, while relying partially on two references
`
`(Kanebo and Evans) cited in the 509 Petition, the 507 Petition: (i) cited eight new
`
`references in proposed combination with Kanebo or Evans; and (ii) detailed eight
`
`new grounds of unpatentability demonstrating that all claim elements were known
`
`in the prior art and that a rationale existed for combining the references. A new
`
`expert declaration also supported the 507 Petition. Ex. 1043 (“507 Decl.”).
`
`2
`
`
`
`509 Petition
`Grounds
`
`507 Petition
`Grounds
`
`New Prior Art
`Reference(s)
`
`Ground 2: Kanebo
`(§103)
`Claims 6-7
`
`Ground 1: Kanebo
`and Cothran
`Claims 6-10
`
`Ground 2: Kanebo,
`Cseh, c261SPEC
`Claim 6
`Ground 3: Kanebo,
`Reid and Bartolo
`Claims 6, 8, 9
`
`Ground 4: Kanebo,
`Cseh, Sime and
`c261SPEC
`Claim 6
`Ground 5: Kanebo,
`Cardin, and Kalla
`Claims 14, 15, 22
`Ground 6: Kanebo
`and Bar-Shalom
`Claims 21 and 23
`
`Ground 2: Kanebo
`(§103)
`Claims 6-7
`Ground 2: Kanebo
`Claims 6-7
`Ground 7: Evans
`and Coffindaffer
`Claims 8-10
`Ground 2: Kanebo
`(§103)
`Claims 6-7
`
`Ground 3: Kanebo
`and Cardin
`Claims 14, 15, 22
`Ground 4: Kanebo,
`Schwen and
`Gibson
`Claims 21 and 23
`Ground 5: Bowser
`and Evans
`Claims 6, 7
`Ground 7: Evans
`and Coffindaffer
`Claims 8-10
`Ground 5: Bowser
`and Evans
`Claim 6
`
`Case IPR2014-00507
`
`
`New Arguments/
`Rationale to
`Combine
`507 Pet. at 12-13,
`15-20; 507 Decl. at
`¶¶ 58-61, 64-65, 68-
`69, 72-73.
`507 Pet. at 22-24;
`507 Decl. at ¶¶ 78-
`82.
`507 Pet. at 26-28,
`29-31; 507 Decl. at
`¶¶ 89-91, 96-98.
`
`Cothran
`(completely new
`as to claims 8-
`10)
`Cseh, and
`c261SPEC
`
`Reid and Bartolo
`(completely new
`as to claims 8-9)
`
`Cseh, Sime and
`c261SPEC
`
`507 Pet. at 33-34;
`507 Decl. at ¶ 101.
`
`Kalla
`
`Bar-Shalom
`
`507 Pet. at 35-38;
`507 Decl. at ¶¶ 106-
`111.
`507 Pet. at 39-41;
`507 Decl. at ¶¶ 115-
`119.
`
`507 Pet. at 45-54;
`507 Decl. at ¶¶ 127-
`131, 134-135, 138-
`139, 141-142.
`
`Ground 7: Evans
`and Cothran
`Claims 6-10
`
`Cothran
`
`
`Ground 8: Evans,
`Cseh, c261SPEC
`Claims 6, 8, 9
`
`Cseh and
`c261SPEC
`
`507 Pet. at 56-59;
`507 Decl. at ¶¶ 150-
`154.
`
`3
`
`
`
`Case IPR2014-00507
`
`
`On July 7, 2014, the Board rejected the 507 Petition under § 325(d) as
`
`presenting “the same or substantially the same” prior art and arguments as
`
`previously raised. Decision at 2, 6-8. Specifically, the Decision found that: (i)
`
`Unilever presented no argument or evidence that the newly cited references were
`
`not known or available to it at the time of filing of the 509 Petition; (ii) all proposed
`
`grounds relied at least in part on references (Kanebo and Evans) previously cited,
`
`notwithstanding the seven1 newly-cited references; (iii) both Unilever petitions
`
`argued obviousness over the primary reference “in view of other art”; and (iv) the
`
`second petition used the 509 Decision “to bolster challenges that were advanced,
`
`unsuccessfully, in the 509 Petition.” Id. at 6-8.
`
`III. LEGAL STANDARDS
`A. The Standard Under 35 U.S.C. § 325(d)
`Section 325(d) provides:
`
`In determining whether to institute or order a proceeding . . . the
`Director may take into account whether, and reject the petition or
`request because, the same or substantially the same prior art or
`arguments previously were presented to the Office.
`
`Logically, arguments based on new prior art should not be considered substantially
`
`the same. Nor was § 325(d) intended to estop a petitioner from correcting
`
`deficiencies that may be raised with respect to an initial petition. Yet, the Board has
`
`not provided clear guidance on the standards governing what prior art or arguments
`
`1
` Petitioner contends that actually eight references were newly cited, as Bartolo was
`not cited in any ground of the 509 Petition.
`
`4
`
`
`
`Case IPR2014-00507
`
`
`qualify as “the same or substantially the same,” resulting in conflicting panel
`
`decisions.
`
`The Standard of Review for Rehearing by an Expanded Panel
`
`B.
`The Board’s own procedures expressly allow for rehearing by a merits or
`
`motions panel where there are conflicting decisions by different panels of the
`
`Board. Board SOP (Revision 13) 2009, Section III(A)(2). Under 37 C.F.R. §
`
`42.71(c), “[w]hen rehearing a decision on petition, a panel will review the decision
`
`for an abuse of discretion.” An abuse of discretion “occurs when a court
`
`misunderstands or misapplies the relevant law or makes clearly erroneous findings
`
`of fact.” Renda Marine, Inc. v. U.S., 509 F.3d 1372, 1379 (Fed. Cir. 2007).
`
`IV. ARGUMENT
`A. The Decision Should Be Reheard by an Expanded Panel
`The Board’s discretion under § 325(d) should be exercised in a uniform and
`
`predictable manner to allow practitioners to reasonably expect that similar
`
`circumstances will lead to similar outcomes. This case presents an opportunity to
`
`set clear guidelines on what qualifies as the “same or substantially the same” prior
`
`art and/or arguments, and the appropriate factors for a § 325(d) analysis. Moreover,
`
`rehearing the Decision will allow the Board to provide appropriate guidance
`
`regarding a petitioner’s ability to correct a petition through a subsequent filing
`
`where deficiencies have been expressly pointed out by the Board. Absent clear
`
`guidance, § 325(d) decisions will remain highly panel-dependent and unpredictable.
`
`5
`
`
`
`Inconsistent Analyses under 35 U.S.C. § 325(d) to Date
`
`1.
`Despite Unilever’s reliance on new art and new arguments supporting
`
`Case IPR2014-00507
`
`
`obviousness, the Board summarily dismissed the 507 Petition without a merits
`
`analysis. This is in sharp contrast to other panel approaches where § 325(d)
`
`challenges were raised. For example, in IPR2013-00368, the panel focused on the
`
`merits and declined to address the § 325(d) argument where petitioner had
`
`demonstrated a reasonable likelihood that the challenged claims were unpatentable.
`
`Paper 8 at 13. Similarly, in IPR2013-00100, despite the petitioner’s reliance on
`
`both an identical and similar prior art reference previously presented to the Office,
`
`the Board declined to reject the petition under § 325(d), instead finding that the
`
`petitioner presented “different arguments and new supporting evidence that were
`
`not before the examiner, [thus] shedding a different light.” Paper 8 at 20.
`
`By way of contrast, in IPR2013-00581, petitioner filed a second petition
`
`proposing new grounds of unpatentability based on combinations of references
`
`partially overlapping with combinations on which an inter partes review had
`
`already been instituted. Paper 15 at 21-22. Despite the newly proposed grounds
`
`being partially based on previously-asserted references, the panel analyzed most of
`
`the proposed grounds on their merits. Id. at 9-20. The panel decided only the
`
`remaining grounds under § 325(d), but specifically noted that similar grounds of
`
`rejection had already been adopted and were being adjudicated as part of the
`
`6
`
`
`
`Case IPR2014-00507
`
`earlier-instituted trial as to those claims. Id. at 21-22. These conflicting approaches
`
`and results under § 325(d) highlight important issues that should be addressed and
`
`clarified by an expanded panel here.
`
`The Proper Scope of Analysis under § 325(d)
`
`2.
`Rehearing by an expanded panel is also warranted in order to clarify and set
`
`forth the proper scope of a § 325(d) analysis. Namely, the Office should address
`
`whether and to what extent a proposed obviousness combination that relies on both
`
`a new and a previously-cited reference can serve as a basis for rejection under
`
`§ 325(d), irrespective of the differences in the art and arguments that might fairly
`
`stem from consideration of the proposed obviousness combination as a whole.
`
`Such summary dismissals appear to contradict Federal Circuit law mandating that
`
`obviousness determinations consider the prior art “as a whole.” In re Merck & Co.,
`
`Inc., 800 F.2d 1091, 1097 (Fed. Cir. 1986).
`
`The Office should likewise address what constitutes “the same or
`
`substantially the same” argument under § 325(d). The Board rejected the 507
`
`Petition because a proposed obviousness ground was based on a previously cited
`
`reference “in view of other art.” Decision at 7. However, the panel declined to
`
`consider what the “other prior art” taught, as well as the newly proffered reasons for
`
`combining the prior art disclosures to arrive at the invention. Id.
`
`In the broadest sense, any second petition challenging the same claims will
`
`7
`
`
`
`Case IPR2014-00507
`
`
`necessarily be asserting that the claims are invalid, whether under obviousness or
`
`anticipation grounds. If § 325(d) is interpreted to preclude a second obviousness
`
`argument with some minimal commonality with an earlier argument, the result is
`
`effectively an estoppel. Congress clearly could have designed the statutory
`
`framework to preclude second, follow-on petitions by the same petitioner, yet chose
`
`not to, and instead opted for a more limited estoppel provision under § 315(e).
`
`Given that subsequent petitions carry the same fees and statutory
`
`requirements as an initial petition, petitioners should have the benefit of their latter
`
`petition being decided on the merits—especially where, as here, the second petition
`
`expressly addresses alleged deficiencies in an earlier-filed petition. Clarification of
`
`this “estoppel” issue will minimize similar issues in the future, and will provide fair
`
`notice to petitioners.
`
`B.
`
`The Decision Relies on Erroneous Factual Findings and a
`Misapprehension of Relevant Law
`
`The Board abused its discretion under § 325(d), making both legal and
`
`factual errors, including: i) impermissibly relying on estoppel considerations as
`
`part of its analysis; ii) without legal basis, precluding a petitioner from filing a
`
`second, improved petition with new prior art and arguments; and iii) disregarding
`
`teachings in the newly-cited references and combinations of references that were
`
`not presented previously.
`
`8
`
`
`
`Improper Reliance on Estoppel Considerations
`
`1.
`The Board refused to address Unilever’s references, claiming there was “no
`
`Case IPR2014-00507
`
`
`argument or evidence that the seven newly cited references were not known or
`
`available to [Unilever] at the time of [the first] filing.” Decision at 6. However,
`
`§ 325(d) does not require Unilever to show that the newly cited references were
`
`unknown or unavailable to it at the time of filing the 509 Petition. Nor does the
`
`Board point to any other statute, rule, or case law supporting such a consideration.
`
`Instead, the estoppel effect of a ground of invalidity is governed by 35 U.S.C.
`
`§ 315(e)(1). This provision requires that a final written decision must issue in the
`
`inter partes review before the petitioner is estopped. Only then is the petitioner
`
`barred from requesting a proceeding before the Office on any ground that was
`
`raised or “reasonably could have been raised.” Id. Because no final written
`
`decision has been issued in IPR2013-00509, neither § 315(e)(1) nor § 325(d) permit
`
`the Board to consider whether newly cited references in the 507 Petition could have
`
`been raised previously.
`
`Put simply, the form of estoppel applied by the Board is not authorized by
`
`statute and is therefore improper. C.f. Tafas v. Dudas 541 F. Supp. 2d 805, 814
`
`(E.D. Va. 2008) (finding that USPTO does not have statutory authority to engage in
`
`substantive rulemaking). For this reason alone, the Board abused its discretion and
`
`should reconsider the 507 Petition in accordance with the standard set forth at 35
`
`9
`
`
`
`Case IPR2014-00507
`
`
`U.S.C. § 314(a).
`
`2.
`
`There Is No Statutory, Rule, or Policy Basis for Precluding
`a Petitioner from Filing a Second, Improved Petition
`
`An expanded panel should review the Decision because it precludes a
`
`petitioner in most cases from ever filing a second petition, regardless of its merits.
`
`Nothing in the statutory framework or rules governing inter partes reviews suggests
`
`that a petitioner is barred from filing a second, follow-on petition that expressly
`
`attempts to correct deficiencies noted in a first petition, or that such petitions are
`
`subject to summary rejection under § 325(d) as presenting the “same or
`
`substantially the same” art and argument.
`
`Nor is such an approach good policy. Given the existing page limits and
`
`format requirements that constrain a petitioner’s ability to raise all known prior art
`
`and arguments, the position adopted by the panel in this case will burden the Board
`
`and patent owners with a flood of “initial” petitions attempting to leave no stone
`
`unturned. See, e.g., IPR2014-00535 to 00537 (three petitions filed as to the same
`
`claims of the same patent, each raising different grounds of unpatentability);
`
`IPR2014-00494 to 00498 (five petitions filed as to same patent, each challenging a
`
`subset of the 40 patent claims total). In contrast, a second petition that clearly
`
`addresses alleged deficiencies in a first petition is likely to be a far more efficient
`
`approach for the Board to adequately address legitimate unpatentability issues, yet
`
`would be no more prejudicial to patent owners who are otherwise likely to face
`
`10
`
`
`
`multiple, concurrently-filed petitions presenting an even larger number of grounds
`
`Case IPR2014-00507
`
`
`of unpatentability.
`
`The panel’s refusal to consider a second petition that expressly fills alleged
`
`gaps noted in prior decisions on an earlier petition (e.g., Paper 10 at 14-16; Paper 25
`
`at 3-4) finds no basis in the rules or statutory scheme, thereby warranting
`
`consideration by an expanded panel to fairly address this weighty issue.
`
`3.
`
`The Board Committed Legal Error by Neglecting
`Substantial Differences in the Prior Art
`
`The Board also abused its discretion by making factual errors in determining
`
`that the prior art cited in the 507 Petition is the same or substantially the same.
`
`The Board acknowledged seven of the 507 Petition’s eight newly-cited references,
`
`yet dismissed the petition because each ground included a previously presented
`
`reference (Kanebo or Evans). Decision at 6. The Board erred in not considering
`
`the teachings of the new references/combinations, notwithstanding their partial
`
`reliance on Kanebo or Evans.
`
`In an obviousness analysis based on a combination of references, the
`
`teachings of the references must be considered as a whole; references may not be
`
`attacked individually. Merck, 800 F.2d at 1097. As shown in the table in Section
`
`II above, each of the 507 Petition grounds relied at least partially on one or more
`
`newly-cited references. And as detailed in the Petition and supporting declaration,
`
`each of these combinations, when considered as a whole, presented a new set of
`
`11
`
`
`
`Case IPR2014-00507
`
`
`teachings not present in the original petition—which was the express purpose of
`
`the newly-proposed grounds. The Board therefore committed factual error by not
`
`considering these new teachings to support unpatentability.
`
`The deficiency in the Board’s approach is illustrated by its analysis of claim
`
`10. Claim 10 requires all of the limitations of claims 1 and 2, but recites cellulose
`
`derivatives within a specified charge density range. While the earlier 509 Petition
`
`proposed an obviousness ground based on Evans over Coffindaffer, the 507
`
`Petition argued that claim 10 was obvious in view of Evans over Cothran. Despite
`
`being set forth in the 507 Petition, however, the Decision disregards the teachings
`
`of Cothran—which are not found in Coffindaffer—that: “cationic polymers form a
`
`net-like suspension by bridging miscelles [sic] of the anionic surfactant. The
`
`droplets of insoluble silicone become suspended within this network. …[L]ow
`
`levels of cationic polymer can be highly effective for providing stability.” 507
`
`Petition at 46.
`
`Unilever submits that there is no basis for ignoring teachings that provide a
`
`motivation to combine references and therefore result in substantially different
`
`arguments in comparison to previously proposed grounds of invalidity. Since
`
`Cothran provides a new teaching not found in Coffindaffer, it was factual error for
`
`the Board to find this prior art combination “substantially the same” as the
`
`previously-presented Evans and Coffindaffer combination.
`
`12
`
`
`
`Case IPR2014-00507
`
`
`Furthermore, the Decision fails to even acknowledge let alone address the
`
`fact that no overlap exists for certain grounds as to certain claims. For example,
`
`the 507 Petition proposes that claims 8-10 would have been obvious in view of
`
`Kanebo and Cothran (see Ground 1), yet neither Kanebo nor Cothran was applied
`
`against claims 8-10 in the earlier 509 Petition. It was therefore error for the panel
`
`to dismiss this aspect of Ground 1 in the 507 Petition under § 325(d). Such a result
`
`is also inconsistent with other Board decisions that a reference applied against
`
`different claims in the same patent was not “substantially the same.” See, e.g.,
`
`IPR2012-00041, Paper 19 at 8 (declining to reject a petition under § 325(d) where
`
`the same reference was cited against different claims in the same patent).
`
`To fulfill its duty to identify each matter Unilever believes the Board
`
`misapprehended or overlooked, Unilever directs the Board’s attention to the table
`
`in Section II above, which shows that at least one reference in each new
`
`combination provides new teachings addressing claim elements and/or providing a
`
`rationale to combine the cited references. As such, the table shows each matter
`
`where the Board abused its discretion in refusing to substantively consider the
`
`teachings from the newly-cited prior art that differ from those previously asserted.
`
`C. The 507 Petition Arguments are Not the Same or Substantially the
`Same
`
`The Board also abused its discretion in finding the 507 Petition arguments to
`
`be the same or substantially the same. In reviewing only the invalidity arguments
`
`13
`
`
`
`Case IPR2014-00507
`
`
`of Grounds 5 and 8 against claims 15 and 10, respectively (Decision at 6-7), the
`
`Board erred by not considering all of the new arguments in the newly proposed
`
`grounds and disregarding material differences in the arguments it did review.
`
`For example, the Board asserted that Unilever advanced substantially the
`
`same argument as to claim 10, “namely that claim 10 would have been obvious
`
`over Evans in view of other prior art disclosing cellulose derivatives that overlap or
`
`fall within the specified charge density range.” Id. at 10. As noted in the previous
`
`section, this broad generalization disregards Cothran’s teaching of the role of
`
`cationic polymers in suspending silicone, which in turn provides a rationale for
`
`arriving at the claimed subject matter. See Petition at 46. Given the Board’s
`
`express finding that the earlier-filed 509 Petition lacked an articulated rationale for
`
`combining the elements required by claim 10 (see 509 Decision at 16), the
`
`argument in the 507 Petition providing this allegedly missing rationale simply
`
`cannot be the same or substantially the same as that offered in the 509 Petition.
`
`Likewise, the Board similarly erred in not considering the new arguments
`
`presented with respect to claim 15 based on Kanebo, Cardin and Kalla. As with
`
`claim 10, the Board determined that the 509 Petition’s argument based only on
`
`Kanebo and Cardin failed to provide a rationale for combining the prior art. 509
`
`Decision at 16. As a result, the 507 Petition addressed this deficiency by relying
`
`on the teachings of a third reference, Kalla, which expressly teaches that an
`
`14
`
`
`
`Case IPR2014-00507
`
`antidandruff shampoo preferably contains the claimed form of ZPT in combination
`
`with cationic polymers, such as those taught in Kanebo, for enhancing the
`
`deposition of antidandruff agents. 507 Petition at 34-35. This new argument in the
`
`507 Petition thus addresses the alleged deficiency in the earlier petition by
`
`providing a clear rationale for combining the ZPT particle size taught by Cardin
`
`with the composition of Kanebo. Id. at 36. Given that this argument was allegedly
`
`missing from the 509 Petition, its inclusion in the 507 Petition thus cannot be the
`
`same or substantially the same as what was previously presented, and it was error
`
`for the Board to have concluded otherwise.
`
`V. CONCLUSION
`For the foregoing reasons, Unilever respectfully requests that the Board
`
`withdraw the rejection of the 507 Petition under 35 U.S.C. § 325(d), consider the
`
`prior art and arguments set forth in the 507 Petition on its merits under 35 U.S.C. §
`
`314(a), and authorize inter partes review of claims 6-10, 14, 15, and 21-23 of the
`
`'300 patent.
`
`
`
`15
`
`
`
`Case IPR2014-00507
`
`
`Respectfully submitted,
`
`
`Date: August 6, 2014
`
`
`
`
`
`
`
`
`
`
`
`Edward A. Squillante, Jr.
`Reg. No. 38,319
`
`
`Ronald Koatz
`
`
`Reg. No. 31,774
`
`
`Conopco Inc. dba Unilever
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`By:
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Jeanne M. Gills
`Reg. No. 44,458
`Joseph P. Meara
`Reg. No. 44,932
`Michael R. Houston
`Reg. No. 58,486
`
`Foley & Lardner LLP
`
`Counsel for Petitioner
`
`
`16
`
`
`
`Case IPR2014-00507
`Patent 6,451,300
`
`CERTIFICATE OF SERVICE
`I hereby certify that a true and correct copy of the foregoing REQUEST FOR
`
`RECONSIDERATION BY AN EXPANDED PANEL INCLUDING THE
`
`CHIEF ADMINISTRATIVE PATENT JUDGE UNDER 37 C.F.R. § 42.71(c)-
`
`(d) are being served by electronic mail this 6th day of August, 2014 on counsel for
`
`
`
`Steven W. Miller
`Kim W. Zerby
`Carl J. Roof
`Angela K. Haughey
`THE PROCTOR & GAMBLE
`COMPANY
`299 E. Sixth Street
`Cincinnati, Ohio 45202
`Telephone (513) 983-1246
`Facsimile (513) 945-2729
`miller.sw@pg.com
`zerby.kw@pg.com
`roof.cj@pg.com
`haughey.a@pg.com
`
`
`
`Respectfully submitted,
`
`Patent Owner as follows:
`
`David M. Maiorana
`John V. Biernacki
`Michael S. Weinstein
`JONES DAY
`North Point
`901 Lakeside Avenue
`Cleveland, Ohio 44114
`Telephone (216) 586-3939
`Facsimile (216) 579-0212
`dmaiorana@jonesday.com
`jvbiernacki@jonesday.com
`msweinstein@jonesday.com
`
`Dated: August 6, 2014
`
`
`
`
`
`
`
`By:
`
`
`
`
`
`/Joseph P. Meara/
`Joseph P. Meara
`Reg. No. 44,932
`Foley & Lardner LLP
`Counsel for Petitioner
`
`17
`
`